A symposium organized by the Pharmacogenomics Research Network (PGRN) The field of pharmacogenomics has received considerable attention recently, since President Obama announced the Precision Medicine Initiative earlier this year. Complementing this effort, NIGMS launched a new version of the Pharmacogenomics Research Network (PGRN), which plans to become a focus for pharmacogenomics research in the U.S. and internationally, bringing together scientists and clinicians in diverse fields and across multiple sectors, including clinical pharmacologists in academia, industry and at the FDA.
|
AuthorThe Hub team Archives
January 2019
Categories
All
|